Hyudinaq Eye Drops (Diclofenac Sodium)

Adult dosage

1. During cataract surgery - Preoperative: 1 drop 5 times over 3 hours - Immediately post-surgery: 1 drop 3 times - Maintenance therapy: 1 drop 3-5 times a day according to symptoms. 2. Treatment of anterior segment inflammation 1 drop 4-5 times a day, appropriately adjusting based on symptoms.

This drug should not be used in patients with an allergy to its components or in patients who have experienced asthma or allergic reactions after using other non-steroidal anti-inflammatory drugs like aspirin. Pregnant women after the sixth month should avoid using this drug as it may pose risks to the fetus. Patients with hypersensitivity to aspirin or other non-steroidal anti-inflammatory drugs should use this drug with caution. Wound healing may be delayed during use, and occasionally symptoms like nausea or vomiting may occur. Additionally, transient symptoms such as eye irritation, itching, redness, and blurred vision may occur, so caution is advised. There is a risk of inflammation or ulcers in the cornea, so if any abnormalities in the eyes are felt, use should be stopped immediately and a doctor consulted. Contact lens wearers should definitely remove their lenses before instilling this medication and may reinsert them after 15 minutes. Blurred vision may occur temporarily after administration, so driving or operating machinery should be avoided until vision becomes clear. This drug can mask the symptoms of eye infections, so it should be used along with appropriate treatment in cases of risk of infection. As it can affect blood coagulation, patients at risk of bleeding or taking medications that may induce bleeding should be cautious. When using with other eye drops, a spacing of at least 5 minutes is recommended to prevent dilution of the medication. This drug contains benzalkonium chloride as a preservative, which can discolor contact lenses or cause eye inflammation. In early and mid-pregnancy, it should only be used at a minimum dose and for the shortest duration necessary. After the sixth month of pregnancy, its use should be avoided. It is advisable to avoid its use during breastfeeding for the safety of the infant. The safety of this drug has not been established for pediatric use, so it should be administered to children with caution. This drug is for topical use only and should not be injected directly into the eye. After opening the container, it should be used within one month, and during storage, it should be kept in a cool, dry place out of reach of children.

Serious side effects

• Urticaria
• asthma
• dyspnea
• corneal ulcer
• corneal perforation
• ulcerative keratitis
• thinning of the cornea
• punctate keratitis
• epithelial defects in the cornea
• corneal edema.

Mild side effects

Delayed wound healing, nausea, vomiting, temporary pain (burning or irritation), dryness, redness, postoperative mydriatic symptoms, superficial keratitis, corneal erosion (corneal desquamation), temporary blurred vision, redness, photophobia, keratitis (punctate keratitis), mild to moderate eye irritation, ocular pruritus immediately after administration, ocular hyperemia, blurred vision, punctate keratitis, corneal disorders, conjunctival hyperemia, allergic conjunctivitis, eyelid erythema, ocular allergies, eyelid edema.

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, preferably at a cool temperature below 10 degrees. Storing it this way helps maintain the drug's efficacy and prevent degradation.

Appearance

The colorless to yellowish liquid is contained in a colorless transparent plastic bottle as eye drops.

Package unit

6 milliliters / bottle